JetMeds develops wearable micro-dispensers and software to optimize medication dosing for animals. Their platform delivers precise drug amounts, potentially improving efficacy while using less medication. The initial application focuses on companion animals, with plans to expand to other animal and human health markets.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Animals often require precise medication dosing, but current methods like pills or injections can be inaccurate and inconvenient. This can lead to reduced drug efficacy, increased side effects, and difficulty in managing chronic conditions.
Solution
JetMeds is developing a wearable micro-dispenser platform that optimizes medication delivery for animals. The system utilizes a programmable micro-pump to administer precise drug amounts transdermally or subcutaneously, improving therapeutic outcomes while minimizing waste. The platform includes a software component for remote monitoring and dose adjustments by veterinarians. The initial focus is on companion animals, offering a more convenient and effective alternative to traditional medication methods.
Target Audience
The primary target audience includes veterinarians specializing in companion animal care and pet owners seeking improved medication management for their animals.
Features
- Wearable micro-dispenser device for precise drug delivery
- Programmable micro-pump technology for accurate dosing
- Transdermal and subcutaneous administration options
- Remote monitoring and dose adjustment capabilities via software platform
- Secure data transmission and storage
- Integration with veterinary practice management systems
- Real-time alerts for medication adherence and potential adverse events